chr9-99105255-TGGCGGCGGCGGC-T

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP6BS2

The NM_004612.4(TGFBR1):​c.67_78delGCGGCGGCGGCG​(p.Ala23_Ala26del) variant causes a conservative inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000776 in 1,043,432 control chromosomes in the GnomAD database, with no homozygous occurrence. It is difficult to determine the true allele frequency of this variant because it is of type DEL_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.000098 ( 0 hom., cov: 30)
Exomes 𝑓: 0.000074 ( 0 hom. )

Consequence

TGFBR1
NM_004612.4 conservative_inframe_deletion

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:2

Conservation

PhyloP100: 2.84

Publications

24 publications found
Variant links:
Genes affected
TGFBR1 (HGNC:11772): (transforming growth factor beta receptor 1) The protein encoded by this gene forms a heteromeric complex with type II TGF-beta receptors when bound to TGF-beta, transducing the TGF-beta signal from the cell surface to the cytoplasm. The encoded protein is a serine/threonine protein kinase. Mutations in this gene have been associated with Loeys-Dietz aortic aneurysm syndrome (LDAS). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008]
TGFBR1 Gene-Disease associations (from GenCC):
  • familial thoracic aortic aneurysm and aortic dissection
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • Loeys-Dietz syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • Loeys-Dietz syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia, Genomics England PanelApp, G2P
  • multiple self-healing squamous epithelioma
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP6
Variant 9-99105255-TGGCGGCGGCGGC-T is Benign according to our data. Variant chr9-99105255-TGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 516727. Variant chr9-99105255-TGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 516727. Variant chr9-99105255-TGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 516727. Variant chr9-99105255-TGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 516727. Variant chr9-99105255-TGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 516727. Variant chr9-99105255-TGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 516727. Variant chr9-99105255-TGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 516727. Variant chr9-99105255-TGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 516727. Variant chr9-99105255-TGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 516727. Variant chr9-99105255-TGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 516727. Variant chr9-99105255-TGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 516727. Variant chr9-99105255-TGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 516727. Variant chr9-99105255-TGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 516727. Variant chr9-99105255-TGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 516727. Variant chr9-99105255-TGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 516727. Variant chr9-99105255-TGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 516727. Variant chr9-99105255-TGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 516727. Variant chr9-99105255-TGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 516727. Variant chr9-99105255-TGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 516727. Variant chr9-99105255-TGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 516727. Variant chr9-99105255-TGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 516727. Variant chr9-99105255-TGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 516727. Variant chr9-99105255-TGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 516727. Variant chr9-99105255-TGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 516727. Variant chr9-99105255-TGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 516727. Variant chr9-99105255-TGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 516727. Variant chr9-99105255-TGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 516727. Variant chr9-99105255-TGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 516727. Variant chr9-99105255-TGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 516727. Variant chr9-99105255-TGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 516727. Variant chr9-99105255-TGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 516727. Variant chr9-99105255-TGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 516727.
BS2
High AC in GnomAd4 at 14 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TGFBR1NM_004612.4 linkc.67_78delGCGGCGGCGGCG p.Ala23_Ala26del conservative_inframe_deletion Exon 1 of 9 ENST00000374994.9 NP_004603.1 P36897-1Q5T7S2B4DXN7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TGFBR1ENST00000374994.9 linkc.67_78delGCGGCGGCGGCG p.Ala23_Ala26del conservative_inframe_deletion Exon 1 of 9 1 NM_004612.4 ENSP00000364133.4 P36897-1

Frequencies

GnomAD3 genomes
AF:
0.0000983
AC:
14
AN:
142424
Hom.:
0
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.0000510
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000206
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000413
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000108
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000744
AC:
67
AN:
900906
Hom.:
0
AF XY:
0.0000781
AC XY:
33
AN XY:
422736
show subpopulations
African (AFR)
AF:
0.000115
AC:
2
AN:
17388
American (AMR)
AF:
0.000357
AC:
1
AN:
2804
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
7300
East Asian (EAS)
AF:
0.000109
AC:
1
AN:
9216
South Asian (SAS)
AF:
0.0000554
AC:
1
AN:
18064
European-Finnish (FIN)
AF:
0.000194
AC:
1
AN:
5142
Middle Eastern (MID)
AF:
0.000512
AC:
1
AN:
1952
European-Non Finnish (NFE)
AF:
0.0000730
AC:
59
AN:
807708
Other (OTH)
AF:
0.0000319
AC:
1
AN:
31332
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
4
8
11
15
19
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000982
AC:
14
AN:
142526
Hom.:
0
Cov.:
30
AF XY:
0.0000865
AC XY:
6
AN XY:
69400
show subpopulations
African (AFR)
AF:
0.0000509
AC:
2
AN:
39330
American (AMR)
AF:
0.000206
AC:
3
AN:
14554
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3342
East Asian (EAS)
AF:
0.000415
AC:
2
AN:
4824
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4608
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
8144
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
266
European-Non Finnish (NFE)
AF:
0.000108
AC:
7
AN:
64622
Other (OTH)
AF:
0.00
AC:
0
AN:
1984
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
37

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Familial thoracic aortic aneurysm and aortic dissection Uncertain:1Benign:1
Dec 12, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant, c.67_78del, results in the deletion of 4 amino acid(s) of the TGFBR1 protein (p.Ala23_Ala26del), but otherwise preserves the integrity of the reading frame. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with TGFBR1-related conditions. ClinVar contains an entry for this variant (Variation ID: 516727). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Nov 15, 2021
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

TGFBR1-related disorder Uncertain:1
Dec 07, 2022
PreventionGenetics, part of Exact Sciences
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The TGFBR1 c.67_78del12 variant is predicted to result in an in-frame deletion (p.Ala23_Ala26del). To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.29% of alleles (or four heterozygous alleles) in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/9-101867537-TGGCGGCGGCGGC-T). The allele frequency data for this variant should be interpreted with caution due to insufficient coverage. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -

not provided Benign:1
Aug 17, 2022
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

See Variant Classification Assertion Criteria. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
2.8
Mutation Taster
=191/9
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11466445; hg19: chr9-101867537; API